UP

Umang Piyushbhai Mewada

Active Director Director DIN 09819383
DIN 09819383 First appointment Dec 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Umang Piyushbhai Mewada

Data last updated:

Umang Piyushbhai Mewada is a Director at Sukrom Healthcare Private Limited (since 2022). The company operates in Chemicals.

DIN 09819383
Primary Designation Director
Industry Chemicals
First Appointment 10 Dec 2022
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sukrom Healthcare Private Limited U24299GJ2022PTC137319
Director10 Dec 20222022Active

Directorship timeline

Open interactive timeline →
Sukrom Healthcare Private Limited
Premium access

Shareholding and investment profile for Umang Piyushbhai Mewada

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Umang Piyushbhai Mewada

Umang Piyushbhai Mewada currently holds 1 directorship: Sukrom Healthcare Private Limited (Director, since 10 Dec 2022).

Umang Piyushbhai Mewada was first appointed on 10 Dec 2022 as Director at Sukrom Healthcare Private Limited.

The current boards of Umang Piyushbhai Mewada's companies include Hitendrakumar Jayantibhai Patel (Sukrom Healthcare Private Limited), Krunal Kirtikumar Shah (Sukrom Healthcare Private Limited), Swati Shah (Sukrom Healthcare Private Limited), Vipulbhai Mansukhbhai Kothiya (Sukrom Healthcare Private Limited), Vishalkumar Shankarbhai Patel (Sukrom Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available